IO BIOTECH INC's ticker is and the CUSIP is 449778109. A total of 18 filers reported holding IO BIOTECH INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,837,119 | -29.6% | 2,055,883 | 0.0% | 0.04% | -20.0% |
| Q2 2023 | $4,029,531 | +4.8% | 2,055,883 | 0.0% | 0.06% | -3.5% |
| Q1 2023 | $3,844,501 | -18.7% | 2,055,883 | 0.0% | 0.06% | -19.7% |
| Q4 2022 | $4,728,531 | -15.1% | 2,055,883 | 0.0% | 0.07% | -31.1% |
| Q3 2022 | $5,571,000 | -42.0% | 2,055,883 | 0.0% | 0.10% | -45.8% |
| Q2 2022 | $9,601,000 | +0.2% | 2,055,883 | 0.0% | 0.19% | +8.6% |
| Q1 2022 | $9,580,000 | -6.5% | 2,055,883 | 0.0% | 0.18% | +0.6% |
| Q4 2021 | $10,243,000 | – | 2,055,883 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 3,640,015 | $5,132,421 | 1.57% |
| Vivo Capital, LLC | 6,173,439 | $8,704,549 | 0.95% |
| Stonepine Capital Management, LLC | 1,975,308 | $2,785,184 | 0.92% |
| Novo Holdings A/S | 5,747,067 | $8,103,364 | 0.60% |
| Pivotal bioVenture Partners Investment Advisor LLC | 864,197 | $1,218,518 | 0.49% |
| Logos Global Management LP | 493,827 | $696,296 | 0.09% |
| PFM Health Sciences, LP | 1,353,453 | $1,908,369 | 0.09% |
| ARMISTICE CAPITAL, LLC | 2,148,000 | $3,028,680 | 0.05% |
| Avoro Capital Advisors LLC | 2,055,883 | $2,837,119 | 0.04% |
| Alyeska Investment Group, L.P. | 987,654 | $1,392,592 | 0.01% |